Venter Targets Life Extension With New Genomic Research Company
This article was originally published in The Pink Sheet Daily
Executive Summary
The former Celera CEO has raised $70 million for a new organization that will use genomic, biochemical and microbiome data to find stem cell-based treatments for aging-related disorders.